The Enterprise Value as of December 2025 (TTM) for Mesoblast Limited (MSB.AX) is 2.32B

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.32B. This represents a change of 185.21% compared to the average of 814.00M of the last 4 quarters.

Mesoblast Limited (MSB.AX) Historical Enterprise Value (quarterly & annually)

How has MSB.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 700.17M. The current 2.32B Enterprise Value has changed 33.06% with respect to the historical average. Over the past ten years (40 quarters), MSB.AX's Enterprise Value was at its highest in in the December 2024 quarter at 2.28B. The Enterprise Value was at its lowest in in the June 2025 quarter at -33001000.00.

Mesoblast Limited (MSB.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mesoblast Limited (MSB.AX) Average Enterprise Value

How has MSB.AX Enterprise Value performed in the past?

The current Enterprise Value of Mesoblast Limited (MSB.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mesoblast Limited (MSB.AX) Enterprise Value vs. Peers

How is MSB.AX’s Enterprise Value compared to its peers?

Mesoblast Limited’s Enterprise Value is less than Neuren Pharmaceuticals Limited (2.36B), greater than Clarity Pharmaceuticals Ltd (1.11B), less than Summerset Group Holdings Limited (4.83B), greater than PYC Therapeutics Limited (711.20M), greater than Dimerix Limited (289.05M), greater than Starpharma Holdings Limited (139.65M), greater than Island Pharmaceuticals Limited (106.53M), greater than Immutep Limited (493.55M), greater than NeuroScientific Biopharmaceuticals Limited (28.32M), greater than Cynata Therapeutics Limited (56.69M),

Build a custom stock screener for Mesoblast Limited (MSB.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MSB.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.